脂质相关的多基因风险评分及其与斑块破裂与侵蚀的关联
Tomoyo Hamana1, Brady Gaynor2, Alyssa Grogan1
1CVPath Institute, Inc, Gaithersburg, MD (T.H., A.G., A.T.-G., R.K., T. Shiraki, T. Sekimoto, T.T., K.F., T.N., Y.A., D.W., K.M.D., R.V., A.V.F.).
Arteriosclerosis, thrombosis, and vascular biology
|December 23, 2025
概括
高胆固醇的多基因风险评分 (PRS) 显示,高胆固醇与斑块破裂有很强的联系,这是心脏病发作的主要原因. 高甘油的遗传风险与斑块破裂不太强烈相关,但与血栓性冠状动脉疾病 (CAD) 有关.
科学领域:
- 心血管遗传学 心血管遗传学
- 病理学 病理学 病理学
- 分子生物学分子生物学
背景情况:
- 显著的动脉硬性斑块形态有助于急性冠状动脉综合征和心脏突然死亡.
- 了解不同类型斑块的遗传基础对于有针对性的预防策略至关重要.
- 高胆固醇血症和高三糖血症是冠状动脉疾病 (CAD) 的主要危险因素.
研究的目的:
- 评估对高胆固醇血症和高甘油三血症遗传风险对特定斑块形态,即斑块破裂和侵蚀的差异性贡献.
- 调查脂质多原风险评分 (PRS) 与冠状动脉样硬化的独特病理特征之间的关联.
主要方法:
- 从954个突发死亡尸检病例的DNA样本中进行了基因定型.
- 特定于LDL (低密度脂蛋白) 和特定于甘油三蛋白的PRS是使用全基因组关联研究数据构建的,不包括与这两种特征相关的变异.
- 进行了统计分析,以评估PRS和斑块形态之间的关联,并根据人口结构进行调整.
主要成果:
- 较高的LDL特异性PRS与增加的斑块破裂,严重的光线缩小 (≥75%),血栓性CAD和CAD相关死亡显著相关.
- 三甲糖特异性PRS显示与血栓性CAD有显著的关联,并趋向于与斑块破裂相关.
- 在脂质特异性PRS和斑块侵蚀之间没有发现显著的关联.
结论:
- 这项研究是第一个将脂质特异性PRS与明显的斑块形态联系在一起的研究,这表明斑块破裂和侵蚀的不同病原性途径.
- 基于脂质资料的遗传风险分层可能有助于识别患有斑块破裂风险较高的个体,并指导降脂干预措施.
- 需要进一步的研究来阐明斑块侵蚀的病原体及其独特的遗传风险因素.
相关概念视频
Atherosclerosis I: Introduction
765
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
765
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
362
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
362
Coronary Artery Disease II: Pathophysiology
336
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
336
Blood Studies for Cardiovascular System III: Serum Lipid Profile
532
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
532
Atherosclerosis III: Management
291
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
291
Coronary Artery Disease I: Introduction
846
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
846


